MedPath

Vimelinspec solution for injection

Registration Number: MAL20016174HA

Approved
Approval ID

72c9d8d88c3820e3

Registration Number

MAL20016174HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

100 mlAvailable
Package Size: 100 ml
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

LINCOMYCIN HCLActive
Monograph: lincomycin hcl
SPECTINOMYCIN SULFATEActive
Monograph: spectinomycin sulfate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vimelinspec solution for injection - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform